Oral News and Research

RSS

FDA approves Lamisil for child treatment of scalp ringworm

The U.S. Food and Drug Administration announced the approval of Lamisil Oral Granules for the treatment of tinea capitis, a fungal infection of the scalp, in children ages 4 years and older.

29 Sep 2007

Gold nanorods coated with multilayer polyelectrolyte as contrast agents for multimodal imaging

A growing body of research has demonstrated that gold nanorods can serve as extremely bright imaging agents.

27 Sep 2007

Probiotic bacteria improve diarrhea in infants

Each year more than half a million infants worldwide, primarily in developing countries, die from diarrhoea caused by rotavirus.

27 Sep 2007

Alcohol cessation significantly reduces cancer risk

Researchers at the Centre for Addiction and Mental Health (CAMH) have clarified the link between alcohol consumption and the risk of head and neck cancers, showing that people who stop drinking can significantly reduce their cancer risk.

27 Sep 2007

Risk of venous thrombosis after air travel exaggerated

In a paper published this week in the open-access journal PLoS Medicine Frits Rosendaal and colleagues from Leiden University Medical Center, Academic Medical Center Amsterdam and Nestle Medical Services, provide the first absolute estimate of risk of venous thrombosis after air travel.

26 Sep 2007

New AstraZeneca compound shows promoise for hormone resistant prostate cancer patients with bone metastases

New Phase II data suggests that ZD4054, a novel compound in development for the treatment of men with Hormone Resistant Prostate Cancer (HRPC), could offer a promising improvement in overall survival in men with metastatic HRPC who were asymptomatic or mildly symptomatic for pain.

26 Sep 2007

Barr Pharmaceutical's Seasonale patent re-issued

Barr Pharmaceuticals, Inc. has announced that the U.S. Patent and Trademark Office (PTO) has reissued the Company's patent, U.S. Patent No. 5,898,032, for Seasonale extended-cycle oral contraceptive.

26 Sep 2007

Risk of DVT on planes so small... not worth taking pills

The debate over the health risks associated with long-haul flights is in the news again with research from Holland.

25 Sep 2007

Increasing elderly population poses huge challenges in cancer care

Huge challenges face healthcare professionals and policy makers in planning for, and providing cancer care over the next decade or so.

25 Sep 2007

New topical lotion safely treats nail fungus without side effects

A new topical lotion that penetrates the skin deeply enough to target and eliminate serious skin infections, but without being systemically absorbed, has shown a high degree of safety and tolerability in patients with onychomycosis, or toenail fungus, a new study has shown.

25 Sep 2007

New Pfizer HIV drug approved for sale in Europe

Drug giant Pfizer has been given approval for it's new HIV drug Celsentri to go on sale in Europe.

24 Sep 2007

UK failing to eat five daily portions of fruit and vegetables

Nearly two thirds of people across the UK are failing to eat the recommended five daily portions of fruit and vegetables - according to research released today.

24 Sep 2007

Diets rich in rapidly-digested carbohydrates may cause fatty liver

Diets rich in rapidly-digested carbohydrates not only expand waistlines, but may also cause fatty liver, a condition that can lead to liver failure and death, finds a new study in mice.

21 Sep 2007

Cell-surface sugar defects may trigger nerve damage in multiple sclerosis patients

Defects on cell-surface sugars may promote the short-term inflammation and long-term neurodegeneration that occurs in the central nervous system of multiple sclerosis patients, according to University of California, Irvine researchers.

21 Sep 2007

Study looks at Naltrexone for alcoholism

Naltrexone is one of four oral medications approved by the U.S. Food and Drug Administration (FDA) for the treatment of alcoholism.

20 Sep 2007

ACTOS associated with reduced risk of heart attack and stroke in patients with type 2 diabetes

Results presented at the 43rd Annual Meeting of the European Association for the Study of Diabetes demonstrate the ability of ACTOS (pioglitazone HCl) to reduce the risk of ischemic cardiovascular disease in patients with type 2 diabetes.

20 Sep 2007

FDA accepts Sucampo's sNDA for Lubiprostone for the treatment of irritable bowel syndrome

Sucampo Pharmaceuticals, Inc., has announced that the supplemental New Drug Application (sNDA) for lubiprostone (8 mcg, oral gel capsules, twice daily) for the treatment of irritable bowel syndrome with constipation (IBS-C) has been accepted for review by the U.S. Food and Drug Administration (FDA).

18 Sep 2007

Effects of tonsillectomy on speech spectrum

Although tonsillectomy is therapeutic for chronic tonsillitis, the procedure has the potential to affect speech quality, by altering the resonant characteristics of the vocal tract, and to modify velopharyngeal function (the closing off of the nose from the mouth during speech).

18 Sep 2007

HPV infection and head and neck cancer

The human papillomavirus (HPV) has been implicated as a cause of cervical cancer in women, but there's another devastating form of cancer also linked to HPV infection - head and neck cancer - and almost no one is talking about it.

18 Sep 2007